P/ 310-827-7707 | F/ 310-574-4002 | MAIL@PROSTATEONCOLOGY.COM
Cancer spreading just outside the capsule of the gland or into the seminal vesicles with otherwise clear scans is termed locally advanced. Modern radiation can effectively control locally advanced cancer when the cancer is confined to the region immediately surrounding the prostate. However, since microscopic metastases may be present, radiation to the pelvic lymph nodes should be discussed. When pelvic radiation is administered, testosterone inactivation pharmaceuticals (TIP) should be added.
Fears about the existence of microscopic metastasis should never be the basis for the decision to forgo treatment to the prostate. Rather, an aggressive approach using every potential means to eradicate the cancer is indicated.
BY MARK SCHOLZ, MD Every year, 200,000 men are diagnosed with prostate cancer. Confusion about optimal treatment is widespread. The doctors even defer to their patients saying, “Since it’s about …
BY MARK SCHOLZ, MD Axumin is an FDA-approved, Medicare-covered scan that can achieve early detection of recurrent prostate cancer after surgery or radiation. For years we have been able to …
BY MARK SCHOLZ, MD There are two different ways to do a prostate biopsy – targeted and random. The random 12-core prostate biopsy is standard and has been in use for over …
BY MARK SCHOLZ, MD Only 5-15% of men describe their sexual function as “undiminished” after prostate cancer surgery.[1] And I’ll venture that 0% describe it as improved. If you accept any degree …